![Matthew Rotenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Rotenberg
Direttore/Membro del Consiglio presso Biosimilars Canada
Posizioni attive di Matthew Rotenberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biosimilars Canada
![]() Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Matthew Rotenberg
Precedenti posizioni note di Matthew Rotenberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
Fresenius Kabi Canada Ltd.
![]() Fresenius Kabi Canada Ltd. Pharmaceuticals: MajorHealth Technology Fresenius Kabi Canada Ltd. health care services. The firm offers intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parental nutrition, and medical devices. The company was founded in 1999 and is headquartered in Toronto, Canada. | Amministratore Delegato | 01/05/2000 | 01/07/2023 |
Statistiche
Distribuzione geografica
Canada | 3 |
Posizioni
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Fresenius Kabi Canada Ltd.
![]() Fresenius Kabi Canada Ltd. Pharmaceuticals: MajorHealth Technology Fresenius Kabi Canada Ltd. health care services. The firm offers intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parental nutrition, and medical devices. The company was founded in 1999 and is headquartered in Toronto, Canada. | Health Technology |
Biosimilars Canada
![]() Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Commercial Services |
- Borsa valori
- Insiders
- Matthew Rotenberg
- Esperienza